|
ZNF480 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
5.38891153922805E-12 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.363600E-02 |
| Stage1-vs-Stage3 |
3.496000E-02 |
| Stage1-vs-Stage4 |
3.579200E-04 |
| Stage2-vs-Stage3 |
1.463280E-03 |
| Stage2-vs-Stage4 |
1.247300E-04 |
| Stage3-vs-Stage4 |
1.465800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
3.30047100760567E-12 |
| Normal-vs-Asian |
1.62536650805123E-12 |
| Caucasian-vs-AfricanAmerican |
9.796600E-01 |
| Caucasian-vs-Asian |
3.670600E-01 |
| AfricanAmerican-vs-Asian |
5.951800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.279950E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.89398999999035E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.749400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.790800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.640200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.954170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.226000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.846000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.38649999995122E-06 |
| Classical-VS-Follicular |
8.72909999838356E-09 |
| Classical-VS-Other |
8.834000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.73683289972359E-12 |
| Tall-VS-Other |
1.946960E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.254960E-01 |
| Follicular-VS-Normal |
1.95055083196394E-12 |
| Other-VS-Normal |
2.12689999999904E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.888400E-02 |
|
|
